Equillium, Inc. - Common Stock (EQ)
0.7700
0.00 (0.00%)
Equillium Inc. is a biotechnology company focused on developing innovative therapeutics to address unmet medical needs in severe autoimmune and inflammatory diseases
The company's research emphasizes harnessing the immune system to create targeted treatments for conditions such as autoimmune disorders and organ transplant rejection. With a commitment to advancing precision medicine, Equillium aims to improve patient outcomes through its pipeline of novel candidates, which are designed to modulate immune responses and provide more effective solutions for patients suffering from debilitating conditions.
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
Via Chartmill · February 6, 2025
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 31, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/31/Carvana.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 31, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 9, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/04/wall-street-subway-shutter.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/04/xrdDAFtptnUKD02-j6917931066219578653-t23.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/04/bz-pharma-briefs.jpeg?width=1200&height=800&fit=crop)
Equillium released topline data from its Phase 2 study of EQ101 in adult patients with alopecia areata, a disease that results in patchy hair loss.
Via Benzinga · June 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/04/Gold-rally.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 4, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · March 26, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/26/image37.jpeg?width=1200&height=800&fit=crop)
Shares of Westport Fuel Systems Inc. (NASDAQWPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
Via Benzinga · March 26, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 25, 2024
![](https://talkmarkets.com/images/logos/talkmarkets.png)
U.S. stocks rallied in February, with the S&P 500 and the Nasdaq Composite Index recording the best month in nearly a decade. Meanwhile, the Dow
Via Talk Markets · March 3, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 19, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 16, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 6, 2024
![](https://cdn.benzinga.com/files/images/story/2023/12/26/image_2.jpg?width=1200&height=800&fit=crop)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · December 26, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/03/evgo_-_logo.jpg?width=1200&height=800&fit=crop)
Gainers
Via Benzinga · August 3, 2023
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
We're starting off the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday morning!
Via InvestorPlace · August 3, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 2, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3192.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 20, 2023